A novel endoscopic approach to brachytherapy in the management of hilar cholangiocarcinoma

American Journal of Gastroenterology

Volumn 101, Issue 8, 2006, Pages 1792-1796

  Simmons, Dia T ^a   Baron, Todd H ^a,c   Petersen, Bret T ^a   Gostout, Christopher J ^a   Haddock, Michael G ^b   Gores, Gregory J ^a   Yeakel, Peter D ^b   Topazian, Mark D ^a   Levy, Michael J ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER SURGERY; CANNULATION; CLINICAL ARTICLE; DOSIMETRY; ENDOSCOPY; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; HEPATOBILIARY SYSTEM; HOSPITALIZATION; HUMAN; IRRADIATION; LIVER TRANSPLANTATION; LOW ENERGY RADIATION; MEDICAL RECORD; OPERATING ROOM; PRIORITY JOURNAL; RADIOSENSITIZATION; SAFETY;

BILE DUCT NEOPLASMS; BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; CHOLANGIOGRAPHY; COMBINED MODALITY THERAPY; ENDOSCOPY, DIGESTIVE SYSTEM; FEASIBILITY STUDIES; FEMALE; HUMANS; IRIDIUM RADIOISOTOPES; MALE; NEOADJUVANT THERAPY; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; STENTS; TREATMENT OUTCOME;

EID: 33746738824     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00700.x     Document Type: Article

References (15)

1. Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321-7.
2. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-8; discussion 458-61.
3. Kipp BR, Stadheim LM, Halling SA, et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004;99:1675-81.
4. Baron TH, Harewood GC, Rumalla A, et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol 2004;2:214-9.
5. Montemaggi M, Shah SK, Morganti AG, et al. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung. Endoscopy 2002;34:555-9.
6. Morganti AG, Trodella MD, Valentini V, et al. Combined modality treatment in unresectable extrahepatic biliary carcinoma. Int J Radiat Oncol Biol Phys 2000;46:913-9.
7. Ove R, Kennedy A, Darwon P, et al. Postoperative endoscopic retrograde high dose-rate brachytherapy for cholangiocarcinoma. Am J Clin Oncol 2000;23:559-61.
8. Urban MS, Siegel JH, Pavlou W, et al. Treatment of malignant biliary obstruction with a high-dose rate remote after-loading device using a 10 F nasobiliary tube. Gastrointest Endosc 1990;3:292-6.
9. Dvorak J, Jandik P, Melichar B, et al. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas. Hepatogastroenterology 2002;49:916-7.
10. Montemaggi P, Morganti AG, Dobelbower RR, et al. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: Is it just for palliation? Radiology 1996;199:861-6.
11. Kocak Z, Ozkan H, Adli M, et al. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct. Radiat Med 2005;23:200-7.
12. 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 2003;57:1357-65.
13. Eschelman DJ, Shapiro MJ, Bonn, et al. Malignant biliary duct obstruction: Long-term experience with Gianturco stents and combined modality radiation therapy. Radiology 1996;200:717-24.
14. Fritz P, Brambs HJ, Schraube P, et al. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys 1994;29:855-61.
15. Bruha R, Petrtyl J, Kubecova M, et al. Intraluminal brachytherapy and self-expandable stents in nonresectable biliary malignancies - the question of long-term palliation. Hepatogastroenterology 2001;48:631-7.